aldevron.com — Lighthouse Performance Report
Full-site audit · mobile & desktop viewports · generated Aug 7, 2026, 12:41 PM
579 pages / viewport
1158 total audits
Simulated throttling
unlighthouse + Lighthouse
📱 Mobile · 579 pages
Average Lighthouse category score across all 579 pages.
Performance score distribution
94%
Good (≥90) — 94%
Needs work (50–89) — 6%
Poor (<50) — 0%
Core Web Vitals (median · % of pages "good")
LCP good: 88%
CLS good: 89%
TBT good: 100%
Lowest-performing pages (bottom 15)
| Page | Perf | LCP | CLS | TBT |
|---|
| /aldevron-cookie-use |
61 |
4.65s |
0.575 |
0ms |
| /aldevron-privacy-policy |
61 |
4.28s |
0.718 |
79ms |
| /aldevron-california-consumer-rights-notice |
64 |
4.12s |
0.642 |
0ms |
| /about-us |
68 |
5.15s |
0.256 |
0ms |
| /blog/dna-plasmids-for-the-genetic-engineering-of-clinical-grade-t-cells |
73 |
5.65s |
0.148 |
0ms |
| /drafts/facilities/breakthrough-campus-fargo |
76 |
1.43s |
0.95 |
0ms |
| /facilities/advance-campus-fargo |
76 |
1.68s |
0.916 |
0ms |
| /facilities/aldevron-madison |
76 |
1.55s |
0.899 |
0ms |
| /facilities/breakthrough-campus-fargo |
76 |
1.54s |
0.9 |
0ms |
| /zArchive/aldevron-lincoln-unpublish-06172024 |
76 |
1.69s |
0.769 |
0ms |
| /crispr-rnp |
77 |
1.09s |
0.629 |
0ms |
| /discover-the-power-of-small-nanoplasmid-vector-platform |
79 |
4.42s |
0.139 |
0ms |
| /custom-manufacturing/ribonucleoproteins |
80 |
1.38s |
0.44 |
0ms |
| /custom-manufacturing/traditional-plasmid-dna |
80 |
1.13s |
0.434 |
0ms |
| /about-us/events/conference-rna-leaders-europe-2026 |
82 |
3.93s |
0.149 |
0ms |
🖥️ Desktop · 579 pages
Average Lighthouse category score across all 579 pages.
Performance score distribution
67%33%
Good (≥90) — 67%
Needs work (50–89) — 33%
Poor (<50) — 0%
Core Web Vitals (median · % of pages "good")
LCP good: 88%
CLS good: 96%
TBT good: 100%
Lowest-performing pages (bottom 15)
| Page | Perf | LCP | CLS | TBT |
|---|
| /aldevron-privacy-policy |
52 |
1.27s |
0.291 |
416ms |
| /drafts/facilities/breakthrough-campus-fargo |
60 |
2.88s |
0.5 |
0ms |
| /crispr-rnp |
62 |
2.51s |
0.609 |
0ms |
| /facilities/breakthrough-campus-fargo |
63 |
2.74s |
0.437 |
0ms |
| /zArchive/aldevron-lincoln-unpublish-06172024 |
66 |
2.13s |
0.497 |
0ms |
| /facilities/aldevron-madison |
68 |
2.03s |
0.436 |
0ms |
| /gmpstart |
68 |
2.49s |
0.274 |
0ms |
| / |
68 |
5.13s |
0.017 |
0ms |
| /custom-manufacturing/ribonucleoproteins |
70 |
1.11s |
0.045 |
634ms |
| /advancing-every-day/our-approach-to-opportunities |
71 |
2.59s |
0.001 |
192ms |
| /drafts/webinar-streamlining-path-discovery |
73 |
4.61s |
0.002 |
0ms |
| /advancing-every-day/the-future-of-rna-a-world-of-opportunity |
74 |
2.59s |
0.001 |
150ms |
| /about-us/news/aldevron-receives-spotlight-at-2021-state-of-the-state-address-for-its-40-plus-covid-19-programs |
74 |
5.66s |
0.026 |
0ms |
| /about-us/news/webinar-advanced-plasmid-technology-improving-safety-and-performance |
74 |
4.91s |
0.001 |
0ms |
| /facilities/advance-campus-fargo |
74 |
3.36s |
0.138 |
0ms |